![Andrew Phillips](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Phillips
Directeur/Membre du Conseil chez
MOONLAKE IMMUNOTHERAPEUTICS
Fortune : - $ au 30/06/2026
Profil
Andrew J.
Phillips is the founder of Nexo Therapeutics, Inc., founded in 2022, serving as President, Chief Executive Officer & Director.
Current jobs include President & Chief Executive Officer at Aleksia Therapeutics, Inc. since 2022; Chairman at OnKure Therapeutics, Inc. since 2024; Director at BiVACOR, Inc., Expansion Therapeutics, Inc., ONK Therapeutics Ltd., Kestrel Therapeutics, Inc., Blossom Biomedicines USA, Inc.; Director at Moonlake Immunotherapeutics AG since 2021; Director at OnKure, Inc. since 2021; Director at Enliven Therapeutics, Inc. since 2022; Independent Director at MoonLake Immunotherapeutics since 2022.
Former jobs include Chief Executive Officer at C4 Therapeutics, Inc. from 2018 to 2020; Chief Executive Officer & Director at Blossom Biosciences Ltd. from 2021 to 2024; Senior Director-Center for Development at The Broad Institute, Inc. from 2014 to 2016; Director at Immuneering Corp.
from 2020 to 2021; Managing Director at Cormorant Asset Management LP from 2020 to 2022; Director at Elevation Oncology, Inc. from 2020 to 2021; Independent Director at Enliven Therapeutics, Inc. from 2020 to 2026; Professor at Yale University from 2010 to 2015; Professor at The University of Colorado from 2001 to 2010; Chief Financial Officer at Helix Acquisition Corp.
from 2021 to 2022.
Education includes undergraduate and doctorate degrees from the University of Canterbury.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 04/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| 17/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Andrew Phillips
| Sociétés | Poste | Début |
|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Directeur/Membre du Conseil | 05/04/2022 |
Aleksia Therapeutics, Inc. | Directeur Général | - |
Nexo Therapeutics, Inc.
 Nexo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer patients | Fondateur | 01/01/2022 |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | 01/04/2021 |
Kestrel Therapeutics, Inc.
 Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology development company | Directeur/Membre du Conseil | - |
ONK Therapeutics Ltd.
 ONK Therapeutics Ltd. BiotechnologyHealth Technology Develops bio cells for anti cancer therapies | Directeur/Membre du Conseil | - |
Blossom Biomedicines USA, Inc. | Directeur/Membre du Conseil | - |
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as drug discovery and development company for RNA-mediated diseases | Directeur/Membre du Conseil | - |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Directeur/Membre du Conseil | 19/01/2022 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Andrew Phillips
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Andrew Phillips
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing epigenetic therapies for the treatment of cancer | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Canterbury
 University of Canterbury Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
BiVACOR, Inc.
 BiVACOR, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Health Technology |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Expansion Therapeutics, Inc.
Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as drug discovery and development company for RNA-mediated diseases | Health Technology |
Cormorant Asset Management LLC/Private Equity/
 Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management/Private Equity/ invests in companies located in the United States. The firm targets companies operating in the fields of life-science and biotech. It provides financing for mezzanine and early stage capital requirements. | Finance |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Health Technology |
ONK Therapeutics Ltd.
ONK Therapeutics Ltd. BiotechnologyHealth Technology Develops bio cells for anti cancer therapies | Health Technology |
Elevation Oncology, Inc.
 Elevation Oncology, Inc. BiotechnologyHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
Helix Acquisition Corp.
 Helix Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Kestrel Therapeutics, Inc.
Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology development company | Commercial Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
MoonLake Immunotherapeutics
 MoonLake Immunotherapeutics Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Blossom Biosciences Ltd.
 Blossom Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Provides molecular and cell biology research services | Commercial Services |
Aleksia Therapeutics, Inc. | |
Blossom Biomedicines USA, Inc. | |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
Nexo Therapeutics, Inc.
Nexo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer patients | Health Technology |
